Research Services

Obesity & Metabolic Health

De Novo Lipogenesis

Muscle Protein Synthesis

Glucose Kinetics

Energy Expenditure

Total Body Water

Amino Acid

Liver Health

De Novo Lipogenesis

Non-Invasive Breath Tests

Oncology

Cell Proliferation

Fibrosis Assessment

Fibrosis & Collagen Turnover

Rare Diseases & Gene Therapy

Urea Cycle Disorder

Rare Disease & Gene Therapy

End Product Nitrogen

Protein Turnover

Targeted Protein Half-life

Explore

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (¹³C), nitrogen-15 (¹⁵N), deuterium (²H), and oxygen-18 (¹⁸O).

Trusted by biomarker teams, clinical ops leaders, and pharma scientists who need validated, regulatory-ready isotope data.

Discover Our End-to-End Support
GI Breath Tests

For patients / consumers

Buy At Home Breath Tests

For healthcare providers

GI Breath Tests for Providers

Explore

We have developed and validated non-invasive breath tests that assess sugar intolerances and gastrointestinal health.

Built for GI clinics, hospitals, and any individual wanting to get tested for chronic stomach problems.
No prescription needed.

FAQ
Resources

Resources

Blog

Client List

Research Learning Center

GI Breath Tests Learning Center
About Us

About us

Accreditations

Quality Assurance

HIPAA Compliance

Good Laboratory Practices

SIBO Prevalence with Crohn’s Disease

Testing and treating patients with Crohn's Disease for SIBO results in improved quality of lfe.

May 21, 2015 · 1 minute read

Small intestinal bacterial overgrowth (SIBO) is has been shown to be prevalent in people with Crohn’s Disease. This study sought to determine the prevalence and efficiency of treatment. Sixty eight (68) subjects with Crohn’s Disease were enrolled in the study. Each subject received a glucose hydrogen breath test to indentify the presence of SIBO. 26.5% of the subjects tested positive for SIBO. These patients were then treated using a combination antibiotic and probiotic regimen. The therapy successfully eliminated SIBO in 87% of the subjects.

Ref: Scand J. Gastreonterol 2015 May

http://www.ncbi.nlm.nih.gov/pubmed/25990116

Back to all blog posts

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (¹³C), nitrogen-15 (¹⁵N), deuterium (²H), and oxygen-18 (¹⁸O).

We have developed and validated non-invasive breath tests that assess sugar intolerances and gastrointestinal health.

SIBO Prevalence with Crohn’s Disease

Other blogs you might like